Form D · Biotechnology

Clear Labs, Inc.

San Carlos, CA · CIK 0001595806

Offering snapshot reported Dec 30, 2024 · SEC filing

Reported sold
$29.1M
Offering amount: $50M
Investors reported
33
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 12, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 30, 2024Initial$29,062,615No comparison33SEC filing
May 28, 2021Initial$59,999,933No comparisonNot reportedSEC filing
May 19, 2020Amendment$39,538,382$20,200,395vs Oct 30, 201828SEC filing
Oct 30, 2018Initial$19,337,987No comparison15SEC filing
Sep 15, 2015Initial$6,179,911No comparison21SEC filing
Jan 3, 2014Initial$1,049,999No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-533720

Source: Form D, filed Dec 30, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sasan Amini Director, Executive
Edward Fan Executive
Ming Fang Director
Jeff Field Executive
Gaurav Garg Director
Mahni Ghorashi Executive
Brian Hogan Executive
Ramin Khaksar Executive
Richard Murdock Director
Farzad Naimi Director, Executive
Kazutaka Ohno Executive
Charlie Piper Director
Michael Robach Director
Nicolas H. Roelofs Director
Mostafa Ronaghi Director
Michael Taylor Director
Greg Yap Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1559 Industrial Road
San Carlos, CA, 94070